All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
BENITEC BIOPHARMA INC. Last Reported: 4/30/2024 Stock Symbol: BNTC

Business Address

3940 TRUST WAY

HAYWARD , CA US 94545

Mailing Address

3940 TRUST WAY

HAYWARD , CA US 94545
Phone Number: (510) 780-0819 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 6/30/2018
Cash and Cash Equivalents $14,100,000.00 $20,374,000.00 $2,477,000.00 $6,600,000.00 $10,537,000.00 $16,534,000.00 $8,630,000.00 $12,329,000.00 $15,727,000.00 $19,769,000.00 $11,988,000.00 $14,010,000.00 $7,450,000.00 $9,801,000.00 $11,400,000.00 $13,786,000.00 $16,631,000.00 $15,718,000.00 $11,879,000.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $157,000.00 $355,000.00 $1,184,000.00 $774,000.00 $356,000.00 $531,000.00 $206,000.00 $338,000.00 $642,000.00 $814,000.00 -- -- -- -- -- -- -- -- --
Total Current Assets $14,366,000.00 $20,796,000.00 $3,729,000.00 $7,395,000.00 $10,975,000.00 $17,081,000.00 $8,841,000.00 $12,672,000.00 $16,372,000.00 $20,608,000.00 $12,407,000.00 $14,383,000.00 $8,056,000.00 $10,809,000.00 -- -- -- $18,756,000.00 --
Property Plant and Equipement $204,000.00 $51,000.00 $87,000.00 $106,000.00 $139,000.00 $179,000.00 $214,000.00 $268,000.00 $323,000.00 $375,000.00 $563,000.00 $610,000.00 $503,000.00 $374,000.00 -- -- -- $470,000.00 --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $69,000.00 $81,000.00 $97,000.00 $105,000.00 $116,000.00 $119,000.00 $156,000.00 $161,000.00 $169,000.00 $185,000.00 $197,000.00 $210,000.00 -- -- -- -- -- -- --
Total Assets $14,999,000.00 $21,353,000.00 $4,464,000.00 $8,220,000.00 $11,905,000.00 $18,115,000.00 $10,064,000.00 $14,014,000.00 $17,836,000.00 $21,379,000.00 $13,428,000.00 $15,512,000.00 $8,916,000.00 $11,587,000.00 -- -- -- $19,235,000.00 --
Accounts Payable -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $3,499,000.00 $5,883,000.00 $4,262,000.00 $3,507,000.00 $2,911,000.00 $3,502,000.00 $2,544,000.00 $3,178,000.00 $2,361,000.00 $1,369,000.00 $2,498,000.00 $887,000.00 $1,180,000.00 $1,349,000.00 -- -- -- $2,641,000.00 --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $197,255,000.00 $197,063,000.00 $168,921,000.00 $168,791,000.00 $168,720,000.00 $168,768,000.00 $152,285,000.00 $152,093,000.00 $151,854,000.00 $151,583,000.00 $138,632,000.00 $138,395,000.00 $128,850,000.00 $128,826,000.00 -- -- -- $127,327,000.00 --
Accumulated Other Comprehensive Loss $-835,000.00 $-952,000.00 $-830,000.00 $-853,000.00 $-898,000.00 $-738,000.00 $-1,506,000.00 $-1,273,000.00 $-1,216,000.00 $-1,455,000.00 $-1,591,000.00 $-1,567,000.00 $-1,775,000.00 $-1,953,000.00 -- -- -- $-1,864,000.00 --
Accumulated Deficit $-184,920,000.00 $-180,641,000.00 $-167,889,000.00 $-163,228,000.00 $-158,831,000.00 $-153,420,000.00 $-143,260,000.00 $-139,985,000.00 $-135,164,000.00 $-130,119,000.00 $-126,116,000.00 $-122,207,000.00 $-119,340,000.00 $-116,636,000.00 -- -- -- $-108,870,000.00 --
Total Stockholders' Equity $11,500,000.00 $15,470,000.00 $202,000.00 $4,713,000.00 $8,994,000.00 $14,613,000.00 $7,520,000.00 $10,836,000.00 $15,475,000.00 $20,010,000.00 $10,930,000.00 $14,625,000.00 $7,736,000.00 $10,238,000.00 $12,336,000.00 $15,251,000.00 $16,968,000.00 $16,594,000.00 $13,844,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $14,999,000.00 $21,353,000.00 $4,464,000.00 $8,220,000.00 $11,905,000.00 $18,115,000.00 $10,064,000.00 $14,014,000.00 $17,836,000.00 $21,379,000.00 $13,428,000.00 $15,512,000.00 $8,916,000.00 $11,587,000.00 -- -- -- $19,235,000.00 --

Statement of Operations

Date 3/31/2024 12/31/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 6/30/2018
Total Revenues -- -- -- $54,000.00 $14,000.00 -- $73,000.00 $25,000.00 -- $59,000.00 $57,000.00 $56,000.00 $55,000.00 $102,000.00 $137,000.00 $110,000.00 $33,000.00 $12,199,000.00 --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $2,566,000.00 $9,531,000.00 $12,774,000.00 $9,588,000.00 $3,761,000.00 $2,660,000.00 $2,171,000.00 $5,926,000.00 $2,780,000.00 $7,020,000.00 $4,700,000.00 $1,942,000.00 $774,000.00 $3,001,000.00 $2,095,000.00 $1,022,000.00 $423,000.00 $4,567,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $4,141,000.00 $6,927,000.00 $19,156,000.00 $14,599,000.00 $10,204,000.00 $4,580,000.00 $13,189,000.00 $9,682,000.00 $4,822,000.00 $13,655,000.00 $9,798,000.00 $6,004,000.00 $2,745,000.00 $8,383,000.00 $5,531,000.00 $3,387,000.00 $1,199,000.00 $9,616,000.00 --
Loss from Operations $-4,141,000.00 $-6,927,000.00 $-19,081,000.00 $-14,531,000.00 $-10,190,000.00 $-4,580,000.00 $-13,116,000.00 $-4,835,000.00 $-4,822,000.00 $-13,596,000.00 $-9,741,000.00 $-5,948,000.00 $-2,690,000.00 $-8,281,000.00 $-5,394,000.00 $-3,277,000.00 $-1,166,000.00 $2,583,000.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-1.64 $-2.64 $-14.12 $-0.67 $-0.20 $-0.47 -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 2,616,288 2,576,347 1,385,818 27,981,161 27,561,766 10,855,710 -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-6.95 $-5.39 $-14.12 $-0.67 $-0.20 $-0.47 -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 2,449,295 2,366,706 1,385,818 27,981,161 19,208,738 10,855,710 -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 160,000,000 160,000,000 160,000,000 160,000,000 160,000,000 40,000,000 40,000,000 40,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- 10,000,000 --
Common Stock Shares Outstanding 2,724,794 2,592,434 1,645,951 27,981,161 27,981,161 25,809,533 8,171,690 8,171,690 8,171,690 8,171,690 4,818,050 4,540,469 1,108,374 1,108,374 -- -- -- 856,765 --
Common Stock Value -- -- -- $3,000.00 $3,000.00 $3,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $5,000.00 $4,000.00 $1,000.00 $1,000.00 -- -- -- $1,000.00 --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- $0.00 --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com